NCT07354100 2026-03-04
(BLOOM)
University of Chicago
Phase 1/2 Not yet recruiting
Clinical Trials
4 trialsNCT07032142 2025-06-22
ARCTURUS
D'Or Institute for Research and Education
Phase 1/2 Not yet recruiting
NCT06827080 2025-02-14
Study on the Safety, Tolerability, and Preliminary Efficacy of 161Tb-NYM032 in Patients with Metastatic Castration-Resistant Prostate Cancer
Mianyang Central Hospital
Phase 1/2 Not yet recruiting
NCT06456138 2024-06-13
Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC
Shanghai Chest Hospital
Phase 1/2 Not yet recruiting